SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-18-018426
Filing Date
2018-04-13
Accepted
2018-04-12 21:49:04
Documents
5
Effectiveness Date
2018-04-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A bp06078x4_defa14a.htm DEFA14A 22208
2 bp06078x4_proxy1.jpg GRAPHIC 157041
3 bp06078x4_proxy2.jpg GRAPHIC 263448
4 bp06078x4_proxy3.jpg GRAPHIC 108045
5 bp06078x4_proxy4.jpg GRAPHIC 21581
  Complete submission text file 0001140361-18-018426.txt   781469
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33137 | Film No.: 18753053
SIC: 2834 Pharmaceutical Preparations